Tangen Biosciences
Latest round
- Series B
Last raised
- Aug 2020
Total raised
- $21M
Investors
- 5
About Tangen Biosciences
Tangen Biosciences, Inc.Tangen Biosciences, Inc. specializes in developing advanced molecular diagnostic tools.The company offers a variety of innovative diagnostic products designed to enhance operational efficiency in healthcare. Their core offerings include advanced molecular testing solutions that facilitate real-time data analysis. These products cater primarily to healthcare institutions, allowing them to streamline diagnostic workflows and improve patient outcomes.Tangen Biosciences, Inc. generates revenue through a combination of subscription-based services for its diagnostic solutions and direct partnerships with healthcare providers. Revenue is primarily derived from annual subscriptions, which include ongoing updates and customer support. Additionally, consulting services are offered to assist clients in integrating and optimizing the diagnostic tools into their operations.Looking ahead, Tangen Biosciences, Inc. plans to expand its product line by introducing new diagnostic tools aimed at enhancing precision medicine capabilities, with expected releases scheduled for 2022. The company is also targeting expansion into new geographic markets, specifically regions in Asia and Europe, by 2023.2 mn will be instrumental in supporting product development and market entry initiatives, as outlined in their strategic growth plan.
Who invested in Tangen Biosciences
5 investors across 2 rounds
See all investors in Tangen Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Tangen Biosciences
Who invested in Tangen Biosciences?
Tangen Biosciences has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Tangen Biosciences raised?
Tangen Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Tangen Biosciences last raise money?
Tangen Biosciences's most recent round on record is a Series B, in Aug 2020.
What does Tangen Biosciences do?
Tangen Biosciences is a medical devices & equipment company.
Where is Tangen Biosciences headquartered?
Tangen Biosciences is headquartered in Branford, US.
Which VCs invest in companies like Tangen Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Tangen Biosciences's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Tangen Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.